913699-84-0 Usage
Uses
Used in Pharmaceutical Industry:
(E)-3-(4-fluoro-2-methoxyphenyl)acrylic acid is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and reactivity allow it to be a key component in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, (E)-3-(4-fluoro-2-methoxyphenyl)acrylic acid is used as a starting material for the synthesis of various agrochemicals. Its properties make it suitable for the development of compounds with pesticidal, herbicidal, or fungicidal activities.
Used in Medicinal Chemistry Research:
(E)-3-(4-fluoro-2-methoxyphenyl)acrylic acid is used as a research tool in medicinal chemistry studies. Its potential pharmacological properties, such as anti-inflammatory and anti-cancer activities, make it an attractive candidate for further investigation and development.
Used in Organic Synthesis:
(E)-3-(4-fluoro-2-methoxyphenyl)acrylic acid is used as a versatile building block in organic synthesis. Its structure and reactivity enable the creation of a wide range of biologically active compounds, contributing to the advancement of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 913699-84-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,6,9 and 9 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 913699-84:
(8*9)+(7*1)+(6*3)+(5*6)+(4*9)+(3*9)+(2*8)+(1*4)=210
210 % 10 = 0
So 913699-84-0 is a valid CAS Registry Number.
913699-84-0Relevant academic research and scientific papers
Hepatitis C virus inhibitors
-
Page/Page column 57, (2017/01/23)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Hepatitis C Virus Inhibitors
-
Paragraph 0291; 0292, (2015/11/02)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Hepatitis C Virus Inhibitors
-
Page/Page column, (2013/05/21)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
